Marco De Dominici

University of Colorado Anschutz Medical Campus

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Chronic interleukin-1 exposure triggers selection for Cebpa -knockout multipotent hematopoietic progenitors”.

Chronic interleukin-1 exposure triggers selection for Cebpa -knockout multipotent hematopoietic progenitors

The Journal of Experimental Medicine(2021)10.1084/jem.20200560

N/A

1.7DataRank · unranked

56 citations

Andrew Goodspeed, James Chavez, Marco De Dominici, Etienne Danis, Vadym Zaberezhnyy +5 more

Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression

Cancer Research(2021)10.1158/0008-5472.can-21-1297

N/A

0DataRank · unranked

31 citations

Svetlana Petruk, Luca Pagliaroli, Marco De Dominici, David Deming, Matthew V. Puccetti +17 more

Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia

Genes(2021)10.3390/genes12091355

N/A

0DataRank · unranked

14 citations

Marco De Dominici, Joseph M. Salvino, Bruno Calabretta, Patrizia Porazzi

Data from Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression

(2023)10.1158/0008-5472.c.6513811.v1

N/A

0DataRank · unranked

0 citations

Svetlana Petruk, Luca Pagliaroli, Marco De Dominici, David Deming, Matthew V. Puccetti +17 more

Data from Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression

(2023)10.1158/0008-5472.c.6513811

N/A

0DataRank · unranked

0 citations

Svetlana Petruk, Luca Pagliaroli, Marco De Dominici, David Deming, Matthew V. Puccetti +17 more